Lifestyle trends and health tips
GSK has secured global rights to a novel multiple myeloma treatment from China's Chimagen Biosciences, enhancing its pipeline with a $750 million investment.
Recent documents highlight significant issues with Medicare's prior-authorization pilot, raising questions about its effectiveness and future rollout.
Businesses can now apply for NIH funding, broadening access to vital resources for health and science advancements.
Trutakna effectively stabilized kidney function and reduced risks in patients with IgA nephropathy, prompting Vera to seek full FDA approval.
A recent study shows exercise helps maintain heart health in astronauts during long-duration space missions, vital for future Mars expeditions.
U.S. health officials announce the end of a historic cyclospora outbreak, yet its origin remains uncertain despite extensive investigations.
Medicaid's new tiered system for assessing medical frailty aims to streamline exemptions for the seriously ill, but raises ongoing concerns.
Novartis investors heighten scrutiny following drug trial failures and the looming expiration of key biologics patents, impacting market confidence.
FDA has approved an advanced AI tool to improve triage for heart attack patients, enhancing care during critical events.
Recent failures of cardiovascular drugs from Novartis and Novo Nordisk may hinder the industry's efforts in Lp(a) treatments.
To counteract vaccine hesitancy, the pro-vaccine movement must reignite enthusiasm and communal spirit, incorporating joy and engagement into advocacy.
The Trump administration plans to issue $500 refund checks to nearly 1 million ACA enrollees without federal subsidies, targeting key swing states prior to elections.
A recent study reveals the long-term impact of platinum-based chemotherapy on DNA mutations in children, raising concerns for future cancer risks.
The FDA has suspended Shoolin Pharma's product shipments to the U.S. due to unsanitary conditions and incomplete testing records found during an inspection.
UnitedHealth's financial support for Rep. Katherine Clark raises questions about its impact on healthcare legislation amid ongoing billing debates.
Oura reveals impressive earnings of $1.2 billion as it prepares for a public offering, positioning itself strongly in the consumer health tech space.
Novartis and Novo Nordisk encounter significant trial failures, raising concerns about their drug development strategies and future pipeline viability.
Key changes to Medicare Advantage plans in Boston are forcing patients, like cancer survivor Eldon Clingan, to seek new providers.
A recent report highlights that disabled workers may face significant health insurance coverage losses as Medicaid work requirements are set to change.
The conflict over measles death counts between CDC leadership and Pennsylvania undermines public health efforts in addressing the outbreak.